electroCore Completes Acquisition of NeuroMetrix, Expanding Bioelectronic Portfolio

electroCore, Inc., a leader in bioelectronic technology, has completed its acquisition of NeuroMetrix, Inc., significantly expanding its portfolio in non-invasive health and wellness solutions. The acquisition includes NeuroMetrix's Quell Fibromyalgia Solution, broadening electroCore's market and strengthening its distribution, especially within the Veterans Affairs (VA) Hospital System. Each NeuroMetrix share was converted to a cash payment of $4.49 and a contingent value right (CVR), linked to sales milestones and future proceedings from NeuroMetrix's DPNCheck business. This integration makes NeuroMetrix an indirect wholly-owned subsidiary of electroCore and delists its shares from Nasdaq. The merger aligns with electroCore's mission to enhance life quality via non-invasive technologies, though it involves risks such as integration challenges and market responses.